Mast cell disease (systemic)

Systemic mast cell disease in cats represents a serious condition involving the abnormal proliferation and accumulation of mast cells throughout internal organs and body systems. Mast cells are normal components of the immune system that play important roles in allergic reactions and immune responses, but when they multiply uncontrollably, they can cause significant damage to multiple organs. Unlike cutaneous mast cell tumors that appear as skin masses, systemic mast cell disease affects internal organs including the spleen, liver, bone marrow, gastrointestinal tract, and lymph nodes. This condition is considered one of the more aggressive forms of mast cell neoplasia in cats and represents a significant concern for affected animals and their owners.

The underlying cause of systemic mast cell disease involves mutations that cause mast cells to proliferate abnormally and accumulate in organs where they cause damage. While the exact triggers for these mutations remain unclear, the condition appears to develop spontaneously in most affected cats. The spleen is most commonly and severely affected, often becoming dramatically enlarged due to massive mast cell infiltration. From the spleen, malignant mast cells can spread to involve the liver, bone marrow, intestinal tract, and other organs. The accumulation of mast cells in these locations disrupts normal organ function and can lead to life-threatening complications.

The impact of systemic mast cell disease on feline health is typically severe, affecting multiple body systems simultaneously and causing progressive deterioration without treatment. Affected cats often experience gastrointestinal symptoms due to the release of histamine and other inflammatory mediators from abnormal mast cells. Vomiting, decreased appetite, and weight loss are common, along with lethargy and general malaise. Splenic enlargement can cause abdominal distension and discomfort. As the disease progresses, bone marrow involvement may lead to anemia and other blood cell abnormalities. The systemic nature of the disease means that cats often feel quite unwell and may decline rapidly without intervention.

While systemic mast cell disease is a serious diagnosis, treatment options exist that can provide meaningful benefit for many affected cats. Surgical removal of the spleen, when disease is concentrated there, can significantly improve survival time and quality of life in appropriate candidates. Chemotherapy medications may help control disease progression, particularly in cats with widespread involvement. Supportive medications that block the effects of histamine released by mast cells can reduce symptoms and improve comfort. The prognosis varies considerably depending on the extent of organ involvement, response to treatment, and individual factors. Early diagnosis and prompt initiation of appropriate therapy offer the best opportunity for extended survival with good quality of life. Close partnership between owners and veterinary specialists ensures optimal care for cats facing this challenging condition.

The primary cause of systemic mast cell disease is the malignant transformation of mast cells, leading to their uncontrolled proliferation and accumulation throughout the body. Mast cells are normally distributed throughout tissues where they function as important immune sentinels, releasing histamine and other inflammatory mediators in response to allergens and pathogens. When genetic mutations occur within these cells, they lose normal growth regulation and multiply excessively. The specific mutations that drive feline systemic mast cell disease are not fully characterized, though research has identified abnormalities in certain cellular signaling pathways in some cases. These transformed cells accumulate primarily in the spleen but spread to involve other organs as the disease progresses.

Genetic and hereditary factors may play a role in susceptibility to mast cell disease, though the exact inheritance patterns are not well defined. Siamese cats appear to have increased risk for mast cell tumors compared to other breeds, suggesting underlying genetic factors. However, mast cell disease occurs across all breeds and in mixed-breed cats, indicating that genetics alone does not determine disease development. No specific genetic test exists to predict which cats will develop mast cell disease. The condition does not appear to be directly inherited from parent to offspring in a simple pattern, but rather may involve complex genetic predispositions that interact with other factors.

Environmental and lifestyle factors that might contribute to mast cell disease development remain poorly understood. Unlike some cancers with clear environmental links, no specific exposures have been definitively associated with increased mast cell tumor risk in cats. Chronic inflammation has been theorized as a potential contributor to various cancers, though its role in mast cell disease specifically is not established. Viral infections, including feline leukemia virus, have been investigated as possible contributors but are not consistently found in affected cats. The indoor or outdoor status of cats does not appear to significantly affect mast cell disease risk. Currently, no modifiable environmental factors have been identified that owners can address to reduce risk.

Certain risk factors are associated with increased likelihood of developing systemic mast cell disease. Age is perhaps the most significant factor, with the condition most commonly diagnosed in older cats, typically over ten years of age. However, younger cats can be affected, and the disease has been reported across a wide age range. The Siamese breed represents the most recognized breed predisposition. Some studies have suggested possible associations with prior vaccination site locations or chronic inflammation, though these associations remain controversial and unconfirmed. Cats with a history of cutaneous mast cell tumors may face increased risk for systemic involvement, warranting careful monitoring.

The mechanism by which systemic mast cell disease develops involves the progressive spread of malignant mast cells from initial sites to involve multiple organs. In many cases, the spleen appears to be the primary site of disease, with massive accumulation of mast cells causing dramatic organ enlargement. From the spleen, malignant cells enter the circulation and seed other organs. The liver frequently becomes involved, with mast cells accumulating and impairing liver function. Bone marrow infiltration leads to impaired production of normal blood cells, potentially causing anemia, low platelet counts, and immune dysfunction. Gastrointestinal tract involvement causes mucosal inflammation and ulceration. The release of histamine and other mediators from accumulated mast cells causes systemic effects including gastrointestinal upset, cardiovascular effects, and allergic-type reactions that contribute to clinical symptoms.

Early warning signs of systemic mast cell disease are often nonspecific and may be attributed to other common conditions in older cats. Initial symptoms frequently include subtle decreases in appetite and gradual weight loss that might be dismissed as normal aging changes. Some cats develop intermittent vomiting or soft stools that may come and go without apparent cause. Decreased activity and increased sleeping might be the first changes owners notice, though these are easily overlooked. Occasionally, cats may show unexplained episodes of facial swelling, itchiness, or skin flushing due to histamine release. Because cats naturally hide signs of illness and these early symptoms are vague, the initial stages of systemic mast cell disease often go unrecognized until more obvious signs develop.

The most commonly observed symptoms of systemic mast cell disease relate to gastrointestinal effects and general systemic illness. Vomiting occurs frequently, often becoming more persistent and severe as the disease progresses. Appetite typically decreases progressively, leading to noticeable weight loss over weeks to months. Many cats develop soft stools or diarrhea, sometimes with blood present. Lethargy becomes more pronounced, with cats spending most of their time resting and showing little interest in normal activities. Some cats develop pale gums due to anemia from bone marrow involvement. Abdominal distension may become noticeable as the spleen enlarges, sometimes dramatically.

Behavioral changes accompany the physical manifestations of systemic mast cell disease and provide important clues for observant owners. Cats with mast cell disease often become withdrawn, seeking isolated resting spots and avoiding interaction with family members. Activity levels decrease substantially, with affected cats reluctant to play, jump, or engage in normal behaviors. Appetite changes may include complete food refusal or pickiness about previously favored foods. Some cats show signs of nausea such as lip-licking, salivation, or turning away from food. Changes in sleeping locations or positions may occur as cats seek comfort from abdominal discomfort. Grooming often decreases, leading to an unkempt coat appearance.

Physical signs of systemic mast cell disease become more apparent as the condition progresses. Abdominal palpation may reveal an enlarged spleen, sometimes dramatically so, feeling like a firm mass in the abdomen. Weight loss becomes visibly apparent, with prominence of the spine and hip bones. Pale gums and mucous membranes indicate anemia. Some cats develop visible bruising or prolonged bleeding from minor injuries due to low platelet counts. Enlarged lymph nodes may be palpable in various locations. Occasional cats develop skin lesions or masses, though systemic disease may exist without obvious cutaneous involvement. Jaundice, a yellow discoloration of the skin and whites of the eyes, may develop if liver function becomes significantly impaired.

Symptom progression in systemic mast cell disease typically follows a pattern of gradual worsening punctuated by acute deteriorations. Initial mild symptoms become more persistent and severe over weeks to months without treatment. Episodes of acute collapse or severe gastrointestinal hemorrhage can occur without warning. Anemia may develop gradually or progress rapidly to dangerous levels. Cats that initially maintained reasonable appetite and activity may decline suddenly as the disease burden increases. The timeline of progression varies considerably between individuals, with some cats declining rapidly over weeks while others have more indolent disease courses lasting months.

Certain symptoms constitute emergencies requiring immediate veterinary attention. Sudden collapse, extreme weakness, or inability to stand may indicate internal bleeding from splenic rupture or severe anemia. Pale or white gums suggest dangerous blood loss or severe anemia requiring urgent transfusion. Labored or rapid breathing may indicate anemia or complications requiring immediate support. Vomiting blood or passing black, tarry stools indicates gastrointestinal hemorrhage. Sudden severe abdominal pain with distension could indicate splenic rupture or other abdominal catastrophe. Any dramatic worsening of symptoms, seizures, or loss of consciousness warrants emergency evaluation, as complications of systemic mast cell disease can be rapidly life-threatening.

The diagnostic process for systemic mast cell disease typically begins when cats present with nonspecific symptoms prompting veterinary evaluation. During the initial examination, the veterinarian performs a thorough physical assessment, often detecting an enlarged spleen through abdominal palpation. The history of symptoms provided by owners helps establish the pattern of illness. The veterinarian will ask about appetite, vomiting, stool quality, activity level, and weight changes. Physical examination may also reveal pale gums suggesting anemia, enlarged lymph nodes, or other abnormalities. Based on findings, the veterinarian will recommend diagnostic testing to determine the underlying cause of symptoms.

Laboratory testing provides crucial information for diagnosing systemic mast cell disease. Complete blood count may reveal circulating mast cells in the bloodstream, which is an important finding when present. Anemia is commonly identified, along with potential abnormalities in white blood cell and platelet counts. Blood chemistry panels evaluate organ function, potentially showing elevated liver enzymes or other abnormalities. Abdominal ultrasound is particularly valuable, typically revealing a dramatically enlarged spleen with abnormal appearance. The liver may also appear abnormal, and other organs can be evaluated for involvement. Fine needle aspiration of the spleen, liver, or other affected organs, guided by ultrasound, obtains cell samples for microscopic examination. Identification of abnormal mast cells in these aspirates confirms the diagnosis.

Differential diagnosis is important because several conditions can cause similar symptoms. Other cancers affecting the spleen, particularly lymphoma and hemangiosarcoma, must be distinguished from mast cell disease. Immune-mediated conditions causing splenic enlargement and blood cell destruction require different treatment approaches. Infectious diseases can cause similar systemic symptoms. Inflammatory bowel disease may cause comparable gastrointestinal signs. The diagnostic testing described above helps differentiate between these possibilities. Histopathology from surgical biopsy provides the most definitive diagnosis but may not be necessary if cytology from aspiration clearly identifies mast cells.

Diagnosis confirmation and staging determine the extent of disease involvement and guide treatment planning. Once mast cells are identified in splenic or other organ aspirates, additional testing determines how widespread the disease has become. Bone marrow aspiration may be performed to assess for bone marrow involvement, which carries prognostic significance. Chest radiographs evaluate for any lung involvement. Complete staging helps veterinarians and owners understand the prognosis and make informed treatment decisions. Grading systems based on mast cell characteristics and extent of involvement help predict behavior and response to treatment. After diagnosis, discussion of treatment options, prognosis, and quality of life considerations helps guide the path forward.

Emergency treatment for cats with systemic mast cell disease focuses on stabilization when life-threatening complications arise. Cats presenting with severe anemia may require blood transfusions to restore oxygen-carrying capacity. Intravenous fluid therapy supports circulation and organ perfusion in debilitated cats. Medications to protect the gastrointestinal tract from histamine-induced acid production and ulceration are typically administered. Anti-nausea medications help control vomiting. Pain management ensures patient comfort. Antihistamines block some effects of histamine released by mast cells. Hospitalization with close monitoring may be necessary until the cat is stable enough for further diagnostic testing or definitive treatment.

Medical management of systemic mast cell disease includes medications to control mast cell effects and chemotherapy to slow disease progression. Antihistamines, including both H1 and H2 receptor blockers, help reduce symptoms caused by histamine release. Famotidine or omeprazole protect the stomach from acid-related damage. Corticosteroids such as prednisolone have direct effects against mast cells and help control symptoms. Chemotherapy options include various protocols, with some veterinary oncologists using tyrosine kinase inhibitors that target specific cellular pathways in mast cell tumors. The medication toceranib phosphate has shown activity against some feline mast cell tumors. Traditional chemotherapy agents like lomustine or vinblastine may also be employed. Treatment protocols are individualized based on disease extent, response, and tolerance.

Surgical removal of the spleen, called splenectomy, represents an important treatment option for cats with disease concentrated in that organ. When the spleen contains the majority of tumor burden, its removal can significantly reduce symptoms and improve survival time. Cats tolerate spleen removal well, as the organ, while beneficial, is not essential for life. The surgery requires general anesthesia and careful technique due to the enlarged, fragile nature of affected spleens. Post-operative recovery typically requires brief hospitalization with pain management and monitoring. Some cats experience dramatic improvement in symptoms following splenectomy. However, if disease has already spread extensively to other organs, splenectomy alone may provide limited benefit.

Supportive care addresses quality of life and symptom management throughout the disease course. Nutritional support encourages adequate caloric intake, sometimes requiring appetite stimulants or highly palatable foods. Anti-nausea medications control vomiting to improve comfort and enable eating. Pain management addresses any discomfort from organ involvement. Medications protecting the gastrointestinal tract continue throughout treatment. Anemia may require periodic blood transfusions in some cats. Careful attention to hydration ensures cats do not become dehydrated from reduced drinking or increased losses. Regular monitoring of blood work guides supportive care adjustments.

Alternative and complementary approaches may provide additional support alongside conventional treatment. Omega-3 fatty acids have anti-inflammatory properties that may provide some benefit. Acupuncture has been used to help control nausea and improve appetite in some cancer patients. Maintaining a calm, stress-free environment supports overall wellbeing. Some integrative veterinarians recommend specific supplements or herbal preparations, though evidence for efficacy in mast cell disease is limited. Any complementary therapies should be discussed with the veterinary team to ensure they do not interfere with conventional treatment or cause harm.

Treatment decisions consider multiple factors including disease extent, cat's overall condition, owner preferences, and practical considerations. Cats with disease limited primarily to the spleen are often good candidates for splenectomy, potentially combined with chemotherapy. Those with widespread disease may benefit more from medical management focused on symptom control and quality of life. Cost of treatment, including surgery and ongoing medications, affects decisions for many families. The cat's age and concurrent health conditions influence treatment tolerance and expected benefit. Realistic discussions about prognosis help owners make informed choices. The goal is always to maximize quality time while minimizing suffering, with decisions guided by the individual cat's best interests.

Recovery timeline following treatment for systemic mast cell disease varies depending on the treatment approach and individual response. Cats undergoing splenectomy typically require several days of hospitalization followed by two to three weeks of home recovery with restricted activity. Improvement in symptoms related to the enlarged spleen, such as abdominal distension and discomfort, is often rapid following surgery. Gastrointestinal symptoms may improve over the following weeks as mast cell burden decreases. Cats starting medical management may see gradual symptom improvement over weeks as medications take effect. Appetite and energy typically improve as treatment controls disease effects, though the timeline varies considerably between individuals.

Post-treatment care for cats with mast cell disease involves ongoing medication administration, monitoring, and supportive measures. Most cats require continued medications to control histamine effects and protect the gastrointestinal tract. Chemotherapy protocols may require periodic administration and monitoring of blood counts. Feeding small, frequent meals of easily digestible food supports nutrition and minimizes gastrointestinal stress. Activity should be gradually increased based on the cat's energy and interest. Follow-up appointments monitor for disease recurrence and treatment side effects. Communication with the veterinary team about any symptom changes ensures timely intervention if needed.

Prognosis for cats with systemic mast cell disease varies widely based on several factors. Cats with disease limited to the spleen that is successfully removed surgically often have better outcomes, with some surviving a year or more with good quality of life. Those with extensive organ involvement at diagnosis typically face shorter survival times, often measured in weeks to months. Response to chemotherapy, when used, significantly impacts outcomes. Young cats in otherwise good health may tolerate treatment better than elderly cats with concurrent conditions. Bone marrow involvement generally indicates a more guarded prognosis. Honest discussions with veterinary specialists help owners understand realistic expectations for their individual cat.

Long-term outlook for cats living with systemic mast cell disease requires ongoing commitment to management and monitoring. Even cats that respond well initially require continued medication and regular veterinary evaluation. Recurrence of disease is common, and treatment may need to be intensified over time. Quality of life assessments should be performed regularly, honestly evaluating whether the cat continues to experience good days with minimal suffering. Some cats maintain excellent quality of life for extended periods, while others decline despite treatment. The focus should remain on maximizing comfortable time together while being prepared to make difficult decisions if quality of life cannot be maintained.

Primary prevention of systemic mast cell disease is not currently possible because the underlying causes remain unclear and no modifiable risk factors have been identified. Unlike some diseases with known preventive measures, mast cell disease appears to develop spontaneously in susceptible individuals. No vaccines, dietary interventions, or environmental modifications have been proven to prevent mast cell tumors. For owners of Siamese cats or other potentially predisposed breeds, awareness of increased risk is the most practical approach. Monitoring for early symptoms and seeking prompt veterinary evaluation for unexplained illness may enable earlier diagnosis when treatment is potentially more effective.

Environmental prevention strategies are limited due to the lack of identified environmental triggers for mast cell disease. Maintaining a healthy, low-stress environment supports overall immune function and wellbeing but is not proven to prevent mast cell disease specifically. Minimizing exposure to potential carcinogens through avoidance of tobacco smoke and certain chemicals represents general cancer prevention advice, though specific relevance to mast cell disease is unconfirmed. Indoor housing is not definitively protective against mast cell disease. Regular parasite prevention and vaccination maintain overall health but do not specifically prevent mast cell tumors.

Dietary approaches to prevention lack specific evidence for mast cell disease but supporting overall health through optimal nutrition is reasonable. Feeding high-quality complete and balanced diets appropriate for the cat's life stage provides foundational nutrition. Maintaining healthy body weight through appropriate feeding reduces general cancer risk. Omega-3 fatty acid supplementation may have general anti-inflammatory and anti-cancer properties, though specific effects on mast cell disease prevention are not established. Avoiding obesity-promoting overfeeding and excessive treat consumption supports overall health. No specific supplements have proven efficacy for mast cell disease prevention.

Regular health maintenance through preventive veterinary care offers the best opportunity for early detection of developing problems. Annual wellness examinations in young to middle-aged cats, increasing to twice yearly in seniors, allow veterinarians to detect subtle abnormalities through physical examination. Routine blood work can identify changes suggesting developing disease before obvious symptoms appear. Discussing any subtle changes in appetite, activity, or behavior with the veterinarian enables early investigation of potential concerns. For cats with a history of cutaneous mast cell tumors, regular monitoring for any signs of systemic involvement is particularly important.

Early intervention when symptoms develop represents the most practical approach to improving outcomes in mast cell disease. Prompt evaluation of unexplained weight loss, chronic vomiting, or decreased activity enables earlier diagnosis. For cats in risk categories such as Siamese or those with prior mast cell tumors, maintaining heightened awareness of potential symptoms supports timely diagnosis. Early detection often means disease is less advanced and potentially more responsive to treatment. Owner education about symptoms to watch for empowers early recognition of problems. Partnership with the veterinary team ensures concerns are addressed promptly and appropriately.

Daily management of cats with systemic mast cell disease requires consistent attention to medication schedules, symptom monitoring, and supportive care. Most cats require multiple daily medications, including antihistamines and gastrointestinal protectants, that must be given reliably for optimal disease control. Developing consistent medication routines helps ensure doses are not missed. Monitoring appetite, food intake, and body weight provides important information about disease status. Observing for vomiting, stool changes, or new symptoms enables early detection of disease progression or complications. Keeping a daily log of observations helps track patterns and provides useful information for veterinary visits.

Home environment modifications support comfort and quality of life for cats with mast cell disease. Providing easily accessible food and water stations encourages adequate intake. Comfortable, soft bedding in quiet locations gives cats restful places to recuperate. Maintaining moderate temperatures avoids stress on cats who may have compromised health reserves. Easy access to litter boxes without requiring jumping or climbing accommodates cats who may have reduced mobility or energy. Reducing household stress through calm, predictable routines supports overall wellbeing. Avoiding strong scents, smoke, or irritants that might exacerbate symptoms is considerate of cats dealing with illness.

Maintaining quality of life remains the central goal of managing cats with systemic mast cell disease. Controlling symptoms effectively allows cats to continue enjoying normal activities to whatever degree they are able. Appetite support through warming food, offering variety, or using appetite stimulants helps maintain nutrition and the pleasure of eating. Gentle interaction and quiet companionship provide emotional comfort without overwhelming ill cats. Pain management ensures cats are not suffering from physical discomfort. Regular assessment of quality of life considers whether cats are eating, grooming, enjoying interactions, and remaining comfortable. The goal is maximizing good days while minimizing suffering.

Ongoing monitoring and veterinary care are essential components of managing mast cell disease. Regular follow-up appointments, typically monthly or more frequently, monitor disease status and treatment response. Blood work assesses for treatment side effects and disease progression. Physical examination detects changes in spleen size or other organ involvement. Adjustments to medications or treatment protocols are made based on response and tolerance. Owners should know what symptoms warrant urgent contact with the veterinarian versus what can wait for scheduled visits. Establishing a relationship with a veterinary oncologist provides specialized expertise for complex decisions.

Caregiver support is vital when managing a cat with a serious illness like systemic mast cell disease. The emotional burden of caring for an ill pet while facing an uncertain prognosis is significant. Connecting with support communities of other pet owners facing similar situations can provide understanding and coping strategies. Honest conversations with the veterinary team about expectations and concerns help manage anxiety. Financial planning for ongoing treatment costs prevents additional stress. Self-care for caregivers prevents burnout and enables continued quality care for the cat. Preparing emotionally for eventual end-of-life decisions, while difficult, prevents crisis decision-making and enables thoughtful consideration of the cat's best interests.

Siamese cats represent the breed with the most clearly identified increased risk for mast cell tumors, including systemic mast cell disease. Multiple studies have documented higher rates of mast cell tumors in Siamese compared to other breeds, with some research suggesting risk may be several times higher than in mixed-breed cats. The reasons for this predisposition are not fully understood but likely involve genetic factors affecting mast cell biology or immune regulation. Owners of Siamese cats should be aware of this increased risk and remain vigilant for potential symptoms, particularly as cats reach middle and older age when mast cell disease most commonly develops.

Beyond Siamese cats, other breeds and cat populations may have elevated risk for mast cell disease, though the associations are less clearly defined. Other Oriental-type breeds related to the Siamese may share some predisposition, though specific data are limited. Older cats across all breeds face higher risk than younger cats, with most cases diagnosed in cats over ten years of age. Mixed-breed cats certainly develop systemic mast cell disease, and any individual cat can be affected regardless of breed background. Male and female cats appear to be affected at similar rates in most studies.

Screening recommendations for at-risk cats focus on awareness and early detection rather than routine testing of healthy cats. No specific screening test exists to identify cats that will develop mast cell disease before symptoms appear. For Siamese cats and others from potentially predisposed backgrounds, owners should be educated about mast cell disease symptoms and encouraged to seek prompt evaluation for unexplained weight loss, chronic vomiting, or abdominal enlargement. Regular wellness examinations with thorough abdominal palpation may detect splenic enlargement before other symptoms become obvious. Cats with a history of cutaneous mast cell tumors should be monitored carefully for any signs of systemic involvement. Early detection through owner awareness and regular veterinary care offers the best opportunity for timely intervention.

Several conditions commonly occur alongside or share features with systemic mast cell disease in cats. Cutaneous mast cell tumors, which appear as masses on the skin, may occur in the same cats and can sometimes precede systemic disease. Cats with widespread mast cell disease may have both skin and internal organ involvement. Histamine-related complications including gastrointestinal ulceration occur commonly due to excessive histamine release from mast cells. Anemia frequently accompanies systemic mast cell disease, resulting from bone marrow infiltration, chronic disease effects, or bleeding. These concurrent issues must be addressed as part of comprehensive management.

Several other conditions may present with symptoms similar to systemic mast cell disease, requiring differentiation for accurate diagnosis. Splenic lymphoma causes similar splenic enlargement and systemic symptoms but has different treatment approaches and prognosis. Hemangiosarcoma of the spleen, another cancer, can cause similar abdominal enlargement and may present with acute bleeding. Immune-mediated blood cell destruction can cause anemia and splenomegaly. Inflammatory bowel disease causes chronic gastrointestinal symptoms that overlap with mast cell disease presentations. Careful diagnostic workup distinguishes between these possibilities to guide appropriate treatment.

Potential complications of systemic mast cell disease and its treatment require vigilant monitoring. Splenic rupture, though uncommon, is a life-threatening emergency requiring immediate surgery. Gastrointestinal hemorrhage from histamine-induced ulceration can cause acute blood loss. Severe anemia may develop requiring transfusion support. Chemotherapy side effects including bone marrow suppression and gastrointestinal toxicity can occur. Secondary infections may develop in immunocompromised cats. Blood clotting abnormalities can lead to bleeding or thrombosis. Regular monitoring enables early detection of complications, and owner awareness of warning signs enables prompt intervention when complications arise.